AREDS Chewable tablets Low zinc
Natural health product licensed in Canada
- Other names
- Vision Essence Low Zinc
- Licence holder
- Vision Essence, Inc.
- NPN or DIN-HM
- 80091188
- Status
- Active licence
- Licence date
- 13 March 2019
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 500 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Zinc: up to 25 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine C Source : Acide ascorbique | 250 mg | 500,000 µg |
| (3R,3'R)-bêta,bêta-Carotène-3,3'-diol Source : Tagetes erecta - Oléorésine (herbe en fleurs) | 1 mg | Not calculated |
| Cuivre Source : Citrate de cuivre (II) | 250 mcg | 500 µg |
| Vitamine E Source : d-alpha tocophérol | 200 UI | Not calculated |
| Vitamine E Source : d-alpha tocophérol | 134 mg AT | Not calculated |
| (3R,3'R,6'R)-bêta,epsilon-carotène-3,3'-diol Source : Tagetes erecta - Oléorésine (herbe en fleurs) | 5 mg | Not calculated |
| Zinc Source : Gluconate de zinc | 12.5 mg | 25,000 µg |
Non-medicinal ingredients
Saveur de baies, Silicate de calcium, Sucralose, Dioxyde de silicium colloïdal, Acide stéarique, Concentré de jus de betterave, Xylitol, Stéarate de magnésium, Phosphate de calcium, dibasique, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Comprimé | 2 Tous les jours |
Uses authorised in Canada
Helps to maintain eyesight in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment optical density. Helps in wound healing. Antioxidant for the maintenance of eye health. Helps to maintain healthy bones, hair, nail and/or skin.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Zinc supplementation can cause a copper deficiency. If you are unsure whether you are taking enough copper, consult a health care practitioner prior to use. Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have cardiovascular disease, diabetes or cancer. Consult a health care practitioner prior to use if you are taking blood thinners.
Source
Official Health Canada record, licence 80091188
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.